HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,765,405 | -63.6% | 170,848 | -67.6% | 0.23% | -63.9% |
| Q2 2023 | $54,259,855 | +36.3% | 527,563 | +44.6% | 0.64% | +18.6% |
| Q1 2023 | $39,807,069 | +17.5% | 364,734 | +22.5% | 0.54% | +19.6% |
| Q4 2022 | $33,883,836 | -76.5% | 297,749 | -87.2% | 0.45% | -77.5% |
| Q3 2022 | $143,997,000 | +658.5% | 2,326,663 | +877.5% | 2.01% | +586.7% |
| Q2 2022 | $18,985,000 | -52.9% | 238,028 | -37.9% | 0.29% | -55.3% |
| Q1 2022 | $40,326,000 | -57.6% | 383,288 | -56.6% | 0.66% | -51.9% |
| Q4 2021 | $95,163,000 | -19.9% | 883,103 | -18.5% | 1.36% | -29.7% |
| Q3 2021 | $118,765,000 | +17.0% | 1,084,213 | +0.0% | 1.94% | +2.4% |
| Q2 2021 | $101,525,000 | +141.4% | 1,084,209 | +137.3% | 1.89% | +102.9% |
| Q1 2021 | $42,050,000 | +297.4% | 456,871 | +215.8% | 0.93% | +232.0% |
| Q4 2020 | $10,582,000 | -85.4% | 144,661 | -84.5% | 0.28% | -88.2% |
| Q3 2020 | $72,678,000 | -8.0% | 935,603 | -34.2% | 2.38% | -23.9% |
| Q2 2020 | $79,033,000 | +109.5% | 1,421,974 | +11.7% | 3.13% | +16.2% |
| Q1 2020 | $37,721,000 | -50.9% | 1,273,494 | -39.9% | 2.70% | -14.1% |
| Q4 2019 | $76,750,000 | – | 2,120,156 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |